SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-24-000519
Filing Date
2024-01-29
Accepted
2024-01-29 06:04:31
Documents
15
Period of Report
2024-01-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT acon_8k.htm   iXBRL 8-K 37074
  Complete submission text file 0001683168-24-000519.txt   256765

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE acon-20240129.xsd EX-101.SCH 3788
3 XBRL DEFINITION FILE acon-20240129_def.xml EX-101.DEF 26648
4 XBRL LABEL FILE acon-20240129_lab.xml EX-101.LAB 36765
5 XBRL PRESENTATION FILE acon-20240129_pre.xml EX-101.PRE 25272
16 EXTRACTED XBRL INSTANCE DOCUMENT acon_8k_htm.xml XML 5713
Mailing Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021
Business Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021 833 275 2266
Aclarion, Inc. (Filer) CIK: 0001635077 (see all company filings)

IRS No.: 473324725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41358 | Film No.: 24569964
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)